American Society of Clinical Oncology

SHERPA: White

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. Traina
    Traina
  5. Dang
    Dang
  6. Lake
    Lake
  7. Fornier
    Fornier
  8. D'Andrea-Carlino
    D'Andrea-Carlino
  9. Modi
    Modi
  10. Iyengar
    Iyengar

Groups

  1. Breast Medicine Service (248)
  2. Department of Medicine (248)
  3. Solid Tumor Oncology Division (248)
  4. Survivorship Research (248)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (97)
  6. Epidemiology and Biostatistics (78)
  7. Biostatistics Service (70)
  8. Population Sciences Research Program (61)
  9. GSK Faculty (35)
  10. Radiology, Department of (33)
Search Within
  1. "Clifford Hudis"
Formats
  1. Meeting Abstract (151)
  2. Journal Article (96)
  3. Guidelines (1)
Groups
  1. Breast Medicine Service (248)
  2. Department of Medicine (248)
  3. Solid Tumor Oncology Division (248)
  4. Survivorship Research (248)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (97)
  6. Epidemiology and Biostatistics (78)

More Groups

People
  1. Clifford Hudis (248)
  2. Larry Norton (88)
  3. Sujata Patil (50)
  4. Andrew Seidman (41)
  5. Maura Dickler (38)
  6. Tiffany Traina (37)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2019 (3)
  4. 2018 (1)
  5. 2017 (6)
  6. 2016 (20)

More Years

Publications
  1. Journal of Clinical Oncology (245)
  2. Journal of Oncology Practice (2)
  3. American Society of Clinical Oncology Educational Book (1)

Results (248)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Accrual of older patients with breast cancer to alliance systemic therapy trials over time: Protocol A151527
    Journal Article

    Freedman, R. A.; Foster, J. C.; Seisler, D. K.; Lafky, J. M.; Muss, H. B.; Cohen, H. J.; Mandelblatt, J.; Winer, E. P.; Hudis, C. A.; Partridge, A. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer
    Meeting Abstract

    Goss, P. E.; Ingle, J. N.; Pritchard, K. I.; Robert, N. J.; Muss, H.; Gralow, J.; Gelmon, K. A.; Whelan, T. J.; Strasser-Weippl, K.; Rubin, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy
    Meeting Abstract

    Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363)
    Meeting Abstract

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, S. D.; You, D.; Samoila, A.; Schiavon, G.; Li, B. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    Meeting Abstract

    McArthur, H. L.; Page, D. B.; Proverbs-Singh, T. A.; Solomon, S. B.; Hudis, C. A.; Norton, L.; Patil, S.; Barrett, J. A.; Lebel, F. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013)
    Meeting Abstract

    King, T. A.; Lyman, J.; Gonen, M.; Reyes, S.; Hwang, E. S. S.; Rugo, H. S.; Liu, M. C.; Boughey, J. C.; Jacobs, L. K.; McGuire, K. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503
    Meeting Abstract

    Innocenti, F.; Owzar, K.; Jiang, C.; Sibley, A.; Mulkey, F.; Carey, L. A.; Tripathy, D.; Schneider, B. P.; Barry, W. T.; Winer, E. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Corben, A.; Moynahan, M. E.; Patil, S.; Boyle, L. A.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save